Pd57-06 Altered Immune Cell Repertoire and Activity After Checkpoint Blockade Immunotherapy With Nivolumab in Renal Cell Carcinoma
Journal of Urology - Netherlands
doi 10.1016/j.juro.2018.02.2650
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2018
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)